Skip to main content
. 2019 Feb 5;19(4):2569–2580. doi: 10.3892/mmr.2019.9937

Figure 3.

Figure 3.

Partial dysregulated lncRNAs and validation of the results of RNA sequencing. (A) Top 10 upregulated and top 10 downregulated lncRNAs with the highest fold-change between patients with DCM (n=8) and controls (n=8). Reverse transcription-polymerase chain reaction validation of five differentially expressed lncRNAs was conducted, including (B) TCONS_00028585, (C) ENST00000439796, (D) TCONS_l2_00009351, (E) ENST00000448134 and (F) ENST00000607876. The experiments were repeated for three times. *P<0.05 and **P<0.01, vs. Ctrl group. lncRNA, long noncoding RNA; DCM, dilated cardiomyopathy; Ctrl, control.